Cargando…
ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study
BACKGROUND: Sarcoid tumors are common in horses and may negatively impact the performance and value of the horse. No known treatment is reliably successful. HYPOTHESES/OBJECTIVES: To determine tolerability, overall response rate, time to response, and progression‐free survival of horses with biopsy‐...
Autores principales: | Saba, Corey, Eggleston, Randall, Parks, Andrew, Peroni, John, Sjoberg, Eric, Rice, Shelbe, Tyma, Jesse, Williams, Jarred, Grosenbaugh, Deborah, Leard, A. Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151478/ https://www.ncbi.nlm.nih.gov/pubmed/35416353 http://dx.doi.org/10.1111/jvim.16425 |
Ejemplares similares
-
Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
por: Saba, Corey
Publicado: (2022) -
Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
por: Rishniw, Mark, et al.
Publicado: (2022) -
Response from Co‐Editor‐in‐Chiefs to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
por: DiBartola, Stephen P., et al.
Publicado: (2022) -
Diagnostic potential of three serum microRNAs as biomarkers for equine sarcoid disease in horses and donkeys
por: Unger, Lucia, et al.
Publicado: (2021) -
Nicoletella semolina in the airways of healthy horses and horses with severe asthma
por: Payette, Flavie, et al.
Publicado: (2021)